Home Patients’ characteristics and their adherence to insulin therapy
Article
Licensed
Unlicensed Requires Authentication

Patients’ characteristics and their adherence to insulin therapy

  • Yunti Fitriani ORCID logo , Liza Pristianty ORCID logo EMAIL logo and Andi Hermansyah ORCID logo
Published/Copyright: January 15, 2020

Abstract

Background

The prevalence of type 2 diabetes mellitus (DMT2) in Indonesia increased significantly from 6.9% (2013) to 8.5% (2018), putting Indonesia in top six countries in the world with maximum DMT2 patients. Patients with uncontrolled DMT2 are at risk for complications. As such, insulin is often administered to keep the levels under control. Unfortunately, poor adherence to insulin therapy is common, reflecting some factors that may affect the therapy. The aim of this study was to identify and analyze the characteristics of patients contributing to adherence to insulin therapy among DMT2 outpatients using the Health Belief Model (HBM) approach.

Methods

A cross-sectional survey was conducted on a sample of 84 DMT2 outpatients in a private hospital in Surabaya between April and May 2019. Respondents were selected using the accidental sampling technique. Data were analyzed using descriptive analysis and chi-square.

Results

The level of respondents’ adherence was high (73.8%). There was no significant relationship between sex, age, level of education, occupation, and duration of use and patient adherence. Using the HBM approach, this study showed a significant relationship between the five components of HBM (perceived susceptibility, perceived severity, perceived benefit, perceived barrier and perceived self-efficacy) and patient adherence.

Conclusions

Patient adherence was influenced primarily by patient belief to the therapy of insulin. The characteristics of patients had no effect on adherence, yet further research is recommended to examine such adherence to a different population.

Acknowledgments

The authors express their gratitude to Surabaya PHC Hospital for providing the opportunity to conduct research. The authors also appreciate DM patients who were willing to be respondents in this study.

  1. Research funding: Research funds obtained from researchers' private funds.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The Health Research Ethics Committee of Surabaya PHC Hospital issued a statement passing the ethical review with No. 004/KEPK/RSPS-2019, issued on April 16, 2019, by the Chairman of the KEPK PHC Hospital Surabaya.

References

[1] American Diabetes Association. Standards of medical care in diabetes 2017. Diabetes Care. 2017;40:S1–S134.10.2337/dci17-0007Search in Google Scholar PubMed

[2] Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.10.1016/j.diabres.2017.03.024Search in Google Scholar PubMed

[3] Badan Penelitian dan Pengembangan Kesehatan Kementerian RI. Riset Kesehatan Basic Health Research. Jakarta: Ministry of Health of the Republic of Indonesia, 2018.Search in Google Scholar

[4] Hartanto D, Mulyani R. Correlation of Insulin-Based Therapy Compliance with Therapy Effectiveness in Type 2 Diabetes Mellitus Patients at Ulin Hospital Banjarmasin. Jurnal Ilmiah Ibnu Sina. 2017;2:287–95.10.36387/jiis.v2i2.117Search in Google Scholar

[5] Perkeni. Consensus on the Management and Prevention of Type 2 Diabetes Mellitus in Indonesia. Jakarta: Perkeni, 2015:11–4.Search in Google Scholar

[6] Fatimah RN. Diabetes Mellitus Type 2. J Majority. 2015;4:93–101.Search in Google Scholar

[7] Srikartika VM, Cahya AD, Hardiati RS. Analysis of Factors Affecting Compliance with Drug Use for Type 2 Diabetes Mellitus Patients. Jurnal Manajemen dan Pelayanan Farmasi. 2016;6:205–212.Search in Google Scholar

[8] Gamayanti V, Ratnasari NL, Bhargah A. The pattern of insulin use in patients with Type 2 Diabetes Mellitus in disease poly in the State General Hospital July-August 2018. Intisari Sains Medis. 2018;9:68–73.10.15562/ism.v9i3.306Search in Google Scholar

[9] Ulum Z, Kusnanto X, Widyawati IY. Compliance Medication for Type 2 Diabetes Mellitus Patients Based on Health Belief Model (HBM) Theory in the Work Area of Mulyorejo Public Health Center in Surabaya. Jurnal Keperawatan Airlangga.2015;4:1–11.Search in Google Scholar

[10] Given CW, Given BA, Gallim RS, Condon JW. Development of scale to measure belief of diabetic patients. Res Nurs Health 1983;6:127–41.10.1002/nur.4770060306Search in Google Scholar PubMed

[11] Van der Ven NC, Adèr H, Weinger K, Van der Ploeg HM, Yi J, Snoek FJ, et al. The confidence in diabetes self-care scale. Diabetes Care 2003;26:713–8.10.1037/t59182-000Search in Google Scholar

[12] Cerkoney KA, Hart LK. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care. 1980;3:594–598.10.2337/diacare.3.5.594Search in Google Scholar PubMed

[13] Nanda OD, Wiryanto RB, Triyono EA. Relationship between antidiabetic drugs consumption and blood glucose level regulation for diabetes mellitus female patients. Research Study. 2018;2:340–348.10.20473/amnt.v2i4.2018.340-348Search in Google Scholar

[14] Krisnawati B, Hari KY, Budi M. Gender differences in the incidence of metabolic syndrome in urban populations in Indonesia. Jurnal Kesehatan Masyarakat Nasional. 2012;7:219–25.Search in Google Scholar

[15] Restuning PD. Diabetes Education in Improving the Effectiveness of Compliance with Setting Diet in Type 2 Diabetes Mellitus. Artikel Penelitian. 2015;15(1):37–41.Search in Google Scholar

[16] Notoatmodjo S. Health Education and Behavior. Jakarta: PT Rineka Cipta, 2010.Search in Google Scholar

[17] Rasdianah N, Martodiharjo S, Andayani TM, Hakim L. Overview of Treatment Compliance for Patients with Type 2 Diabetes Mellitus in Yogyakarta community Health centers. Jurnal Farmasi Klinik Indonesia. 2016;5:249–257.10.15416/ijcp.2016.5.4.249Search in Google Scholar

[18] Vazini H, Barati M. The health belief model and self-care behaviors among type 2 diabetic patients. Iran J Diabetes Obes 2014;6:107–13.Search in Google Scholar

[19] Buglar ME, White KM, Robinson NG. The role of self-efficacy in dental patients’ brushing and flossing: test an extended Health Belief Model. Patient Educ Couns 2010;78:269–72.10.1016/j.pec.2009.06.014Search in Google Scholar PubMed

[20] Chairunisa C, Arifin S, Rosida L. Factors Related to Compliance Behavior Taking Anti-Diabetes Medication in Patients with Type 2 Diabetes Mellitus. Homeostasis. 2019;2:1–12.Search in Google Scholar

Received: 2019-11-03
Accepted: 2019-12-10
Published Online: 2020-01-15

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0330/html
Scroll to top button